![Anti-HPV-18 E6 antibody [HPV-4G3] (STJ16101058)](https://cdn11.bigcommerce.com/s-zso2xnchw9/images/stencil/124x110/products/149774/302520/STJ16101058_1__15043.1646940683.jpg?c=1 "Anti-HPV-18 E6 antibody [HPV-4G3] (STJ16101058)")
![Anti-HPV-18 E6 antibody [HPV-4G3] (STJ16101058)](https://cdn11.bigcommerce.com/s-zso2xnchw9/images/stencil/124x110/products/149774/302521/STJ16101058_2__12133.1646940683.jpg?c=1 "Anti-HPV-18 E6 antibody [HPV-4G3] (STJ16101058)")
![Anti-HPV-18 E6 antibody [HPV-4G3] (STJ16101058)](https://cdn11.bigcommerce.com/s-zso2xnchw9/images/stencil/1280x1280/products/149774/302520/STJ16101058_1__15043.1646940683.jpg?c=1 "Anti-HPV-18 E6 antibody [HPV-4G3] (STJ16101058)")
Anti-HPV-18 E6 antibody [HPV-4G3] (STJ16101058)
SPECIFICATIONS
ClonalityMonoclonal
HostMouse
ConjugationUnconjugated
IsotypeIgG1k
ImmunogenA BALB/c mouse was immunized with HPV-18 E6 synthetic peptide. Fusion partner: X63-Ag8-653.
General Information
| Short Description | Mouse monoclonal anti-HPV-18 E6 for use in ELISA and IHC in Human samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | ELISA/IHC |
| Host | Mouse |
| Reactivity | Human |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Monoclonal |
| Clone ID | HPV-4G3 |
| Isotype | IgG1k |
| Conjugation | Unconjugated |
| Concentration | Can be provided as 100 µg/mL, 500 µg/mL or 1mg/mL. |
| Purification | Affinity purified from tissue culture. |
| Dilution Range | ELISA (solid phase: not known; tracer: 0, 001-100 µg/ml for 30 min at RT). Immunohistology (1-2 µg/ml for 30 min at RT; an appropriate antigen retrieval method for staining of formalin-fixed tissues has not been established to date). |
| Formulation | PBS with 0.02% Sodium Azide. |
| Storage Instruction | Store for up to 1 year at 2-8°C upon receipt. |
Target Information
| Immunogen | A BALB/c mouse was immunized with HPV-18 E6 synthetic peptide. Fusion partner: X63-Ag8-653. |
Additional Info
| Background | Monoclonal antibody HPV-4G3 reacts with HPV-18 E6 peptide. Infection with specific types of HPV has been associated with an increased risk of developing cervical neoplasia. HPV types 6 and 11 have been associated with relatively benign diseases such as genital warts but types 16 and 18 are strongly associated with cervical, vaginal, and vulvar malignancies. |
Information sourced from Uniprot.org